Smiths Group Patents – Key Insights and Stats

Smiths Group has a total of 7595 patents globally, out of which 3732 have been granted. Of these 7595 patents, more than 33% patents are active. The United States of America is where Smiths Group has filed the maximum number of patents, followed by the United Kingdom and Europe. Parallelly, the United Kingdom seems to be the main focused R&D centre and also is the origin country of Smiths Group.

Smiths Group was founded in the year 1851. Smiths Group offers goods and services for the markets for medical devices, energy, communications, and threat and contraband detection.

Do read about some of the most popular patents of Smiths Group which have been covered by us in this article and also you can find Smiths Group patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Smiths Group patent portfolio.

How many patents does the founder and the CEO of Smiths Group have?

The founder Samuel Smith and CEO Paul Keel have 0 patents

How many patents does Smiths Group have?

Smiths Group has a total of 7595 patents globally. These patents belong to 2461 unique patent families. Out of 7595 patents, 2561 patents are active.

How Many Patents did Smiths Group File Every Year?

Smiths Group Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSmiths Group Applications FiledSmiths Group Patents Granted
20231351
2022108147
2021194196
2020268204
2019216191
2018277232
2017230178
2016336191
2015385179
2014473217
2013366205
2012294229
2011340160

How many Smiths Group patents are Alive/Dead?

Smiths Group Patent Portfolio

How Many Patents did Smiths Group File in Different Countries?

Smiths Group Worldwide Patent Filing

Countries in which Smiths Group Filed Patents

CountryPatent
United States Of America1325
United Kingdom931
Europe891
Germany552
China515
Japan453
Canada417
Australia327
Korea (South)172
Mexico150
India140
Austria131
Spain92
Russia85
Brazil74
Hong Kong (S.A.R.)65
Taiwan58
Israel47
France42
Poland38
New Zealand31
South Africa31
Italy29
Singapore26
Denmark25
Norway18
Chile14
Finland13
Argentina12
Netherlands7
Malaysia7
Portugal6
Turkey6
Indonesia6
Gulf Cooperation Council5
Sweden4
Ireland4
Switzerland3
Slovenia3
Croatia2
Serbia2
Yugoslavia/Serbia and Montenegro2
United Arab Emirates2
Hungary1
Thailand1
Saudi Arabia1
Eurasia1
Colombia1
Ecuador1
Belgium1
Peru1
Slovakia1
Czech Republic1
Lithuania1

Where are Research Centres of Smiths Group Patents Located?

R&D Centres of Smiths Group

10 Best Smiths Group Patents

US6744350B2 is the most popular patent in the Smiths Group portfolio. It has received 432 citations so far from companies like Abbott, M2 Medical Group Holdings and Asante Solutions.

Below is the list of 10 most cited patents of Smiths Group:

Publication NumberCitation Count
US6744350B2432
US7699807B2414
US6652486B2381
US7442186B2344
US7572285B2328
US6627154B1294
US7347836B2249
US6985779B2242
US20090099866A1237
US6597760B2213

How many inventions of other companies were rejected due to Smiths Group patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Smiths Group invention. They couldn’t because Smiths Group had protected those before them.

Examiners at the USPTO referred 505 Smiths Group patents in 2919 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Smiths Group patent portfolio are Becton Dickinson, Roche Diabetes and Covidien.

List of the Companies whose Patents were rejected citing Smiths Group –

CompanyNumber of Patent Applications that faced Rejection Citing Smiths Group PatentsNumber of Rejections (102 & 103)
Becton Dickinson48149
Roche Diabetes2871
Covidien2045
Resmed1936
Abbott1753
B Braun Melsungen1631
Carefusion 3031435
Trudell Medical International1322
Medtronic Minimed1230
General Electric1222

Count of 102 and 103 Type Rejections based on Smiths Group Patents

Top Smiths Group Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US7922696B219
US7499739B218
US8192402B216
US20090177769A116
US7731691B214
US6744350B213
US6883364B213
US7033338B213
US7486977B212
US8995517B212
US6652486B212
US8694331B211
US8504179B211
US20080172031A111
US7486693B211

What are Smiths Group key innovation segments?

What Technologies are Covered by Smiths Group?

The chart below distributes patents filed by Smiths Group in different countries on the basis of the technology protected in patents. It also represents the markets where Smiths Group thinks it’s important to protect particular technology inventions.

R&D Focus: How has Smiths Group search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Smiths Group?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.